drug protocol number

SCT21R/006/04

drug sponsor

King Abdullah International Medical Research Center (KAIMRC)

drug study

DEXMEDETOMIDINE

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase